Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000046758 | SCV000221031 | likely pathogenic | Cystic fibrosis | 2015-01-15 | criteria provided, single submitter | literature only | |
Integrated Genetics/Laboratory Corporation of America | RCV000781234 | SCV000919139 | likely pathogenic | not specified | 2018-08-17 | criteria provided, single submitter | clinical testing | Variant summary: CFTR c.3022delG (p.Val1008SerfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. p.Trp1089X, p.Tyr1092X, p.Ala1146fsX2). The variant was absent in 245950 control chromosomes. c.3022delG has been reported in the literature in individuals undergoing carrier screening. This report does not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. |